Viskase Holdings Inc - Company Profile
Powered by 
All the sales intelligence you need on Viskase Holdings Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Viskase Holdings Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Viskase Holdings Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Viskase Holdings Inc (Viskase), formerly Enzon Pharmaceuticals Inc, operates as an acquisition platform, leveraging its net operating loss carryforwards (NOLs) to enhance shareholder value. The company’s intellectual property, experience in specialty pharmaceuticals, and proprietary drug delivery technology represents a major strength. However, the lack of a pipeline and marketed products is a significant concern. Despite this, Viskase can capitalize on the market potential for pancreatic cancer, market potential for head and neck cancer, and increasing demand for biologics. Nevertheless, risks associated with acquisitions and the use of proceeds, rapid technological changes, and stringent regulations could adversely impact its business.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer